$AME

AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance

AMETEK (NYSE: AME) reported record Q2 2026 results. Sales rose 15% to $2.04B and GAAP EPS was $1.77. Adjusted EPS was $2.09, up 17%. Operating cash flow increased 35% to $483.7M. The company raised 2026 adjusted EPS guidance to $8.20 to $8.30 and Q3 adjusted EPS to $2.08 to $2.10.

Original reporting
Published Aug 4, 2026, 11:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 11:49 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AME
Bullish
high confidence
Mentioned
$AME
Relevance
10/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$AMEBullishHigh
01

Why it matters

The key tradable items are record Q2 performance and an increased 2026 outlook, including higher full-year adjusted EPS and Q3 sales/EPS ranges.

02

Market read

A same-day earnings and guidance update with explicit EPS and sales ranges typically drives estimate revisions and near-term positioning.

03

What to watch

The release emphasizes adjusted metrics; traders may scrutinize GAAP vs adjusted trends, acquisition contribution sustainability, and any risk to margins from integration or input costs.

Relevance 10/10Novelty 9/10Timing: guidance update and Q2 results released pre/at market open on Aug. 4, 2026

Background

AMETEK is a diversified industrial technology company reporting results by Electronic Instruments Group (EIG) and Electromechanical Group (EMG).

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

AMETEK reported record Q2 2026 sales of $2.04B, record adjusted EPS of $2.09, and raised full-year adjusted EPS guidance to $8.20-$8.30.

Expected impact

Likely positive reaction and upward bias for estimates, with follow-through dependent on order strength and margin sustainability.

Evidence & confidence

The article discloses both a results beat (record sales/EPS, margin expansion, strong cash flow) and a specific guidance increase for full-year and Q3.

Market effects

Signals continued strength in industrial instrumentation and niche industrial tech demand, potentially supportive for peers with similar end markets.

Primarily US-listed industrials sentiment; could modestly lift broader industrials complex on guidance strength.

Demand strength referenced across semiconductor and commercial aerospace markets may resonate with global industrial supply chains.

Counterpoint

Guidance raises may already be partially anticipated; investors may focus on whether order growth (28% in Q2) can persist into Q3 and beyond.

Key entities

  • AMETEK, Inc.

    Announced record Q2 2026 results and raised full-year 2026 guidance.

  • Electronic Instruments Group (EIG)

    Reported Q2 2026 sales of $1.32B and adjusted operating income up to $384.7M.

  • Electromechanical Group (EMG)

    Reported Q2 2026 sales of $723.2M and adjusted operating income up to $190.5M.

  • David A. Zapico

    Chairman and CEO who commented on orders growth and the raised guidance.

Related articles

$AMEMed

Segment Demand and Strategic Acquisitions Propel Growth

AMETEK (NYSE: AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year over year, beating Wall Street expectations. Non-GAAP EPS was $2.09, 4.8% above consensus. Management cited organic growth, rising orders and backlog of $4.11 billion, and contributions from acquisitions. Full-year guidance was raised, supported by AI, defense, and power grid demand.

$AMEMedAI 8/10

AMETEK, Inc. Q2 2026 Earnings Call Summary

AMETEK reported Q2 2026 momentum driven by multi-year infrastructure build-outs for AI, semiconductors, and power. Organic sales growth accelerated, with a record $4.11B backlog and about 80% expected to ship in 12 months. Core EMG margins rose 290 bps. Full-year 2026 organic sales guidance was raised to mid-to-high single digits; Indicor Instrumentation acquisition of $5B expected to close in H2 with 10% to 12% synergies.

$AMEHigh

AMETEK INC/ (AME): Results of Operations and Financial Condition

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ametek8kexhibit99108042026.htm EX-99.1 Document Exhibit 99.1 AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Aug 4, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30,

$AMEMedAI 8/10

AMETEK’s (NYSE:AME) Q2 CY2026: Strong Sales

AMETEK (NYSE:AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year on year, exceeding Wall Street estimates by 4.4%, according to the company. Non-GAAP adjusted EPS was $2.09, up from $1.78 and 4.8% above consensus. Analysts expect full-year EPS of $8.46, up from $7.96.

$ARTNAMed

ARTESIAN RESOURCES CORP (ARTNA): Results of Operations and Financial Condition

ARTESIAN RESOURCES CORP (ARTNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2026 ARTESIAN RESOURCES CORPORATION (Exact name of re

$UGMed

UNITED GUARDIAN INC (UG): Results of Operations and Financial Condition

UNITED GUARDIAN INC (UG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 United-Guardian Reports Second Quarter Results HAUPPAUGE, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the second quarter and first half of 2026. Se